Thu. 28 Mar 2024, 11:34pm ET
Benzinga
Earnings, Earnings Beats, News
NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 68.75 percent increase over losses of $(0.16) per share from the same period last year.